Westchester Capital Management (New York)’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-263,308
Closed -$3.25M 210
2024
Q4
$3.25M Buy
+263,308
New +$3.02M 0.18% 75

Other funds holding CDMO

Westchester Capital Management (New York)'s CDMO Position: Q1 2025 in Review

Westchester Capital Management (New York) sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 263,308 shares — an estimated $3.25M sold.

Westchester Capital Management (New York) first reported a position in CDMO in Q4 2024 and held it in 1 quarter. The position peaked at $3.25M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Westchester Capital Management (New York) reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 263,308 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $3.25M.
  • Westchester Capital Management (New York) first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • Westchester Capital Management (New York)'s Avid Bioservices, Inc. Common Stock position peaked at $3.25M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2025, filed 14 May 2025.